|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 403/14 | |
| C07D 405/14 | |||
| A61K 31/4184 | |||
| A61P 31/12 |
| (11) | Number of the document | 2601188 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10740116.8 |
| Date of filing the European patent application | 2010-08-04 | |
| (97) | Date of publication of the European application | 2013-06-12 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/044356 |
| Date | 2010-08-04 |
| (87) | Number | WO 2012/018325 |
| Date | 2012-02-09 |
| (72) |
ROMINE, Jeffrey Lee, US
|
| (73) |
Bristol-Myers Squibb Company,
P.O. Box 4000 Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (54) | HEPATITIS C VIRUS INHIBITORS |
| HEPATITIS C VIRUS INHIBITORS |